GSK is 'open-minded collaborator' in big data program
This article was originally published in Scrip
Executive Summary
In an attempt to further display how it has evolved its business model to center on "open-minded" and "collaborative" activities, GlaxoSmithKline has put forward millions of pounds in a big data-focused partnership with other life science initiatives.